A new study in Science Translational Medicine shows the validity of using DNA sequencing in the clinic to identify rare diseases, reports New Scientist's Wendy Zukerman.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.